Objective. Several opioid risk assessment tools are available to prescribers to evaluate opioid analgesic abuse among chronic patients. The objectives of this study are to 1) identify variables available in the literature to predict opioid abuse; 2) explore and compare methods (population, database, and analysis) used to develop statistical models that predict opioid abuse; and 3) understand how outcomes were defined in each statistical model predicting opioid abuse.
Introduction
Medical and nonmedical use of opioids has increased in the United States for the last decade for patients with chronic noncancer pain [1] [2] [3] [4] . Prescriptions of opioid analgesics such as morphine, fentanyl, oxycodone, and hydromorphone have increased dramatically, as shown in multiple studies [1, [5] [6] [7] . According to The National Health and Nutrition Examination Survey, 25% of Americans age 20 years and older have experienced pain that has lasted over 24 hours in the past month [8] .
Despite the clinical importance of opioids in the management of pain, opioids may have significant and adverse societal effects. Notably these can include the epidemic of opioid abuse and opioid use disorder with related socioeconomic and criminal impacts and deaths attributed to overdose [9] . Achieving effective pain management, along with maintaining functionality and healthy participation in society, cannot be accomplished with a high occurrence of opioid addiction. Therefore, understanding the risks and benefits of prescribing opioids is important to reduce the related opioid abuse epidemic [10] [11] [12] [13] .
To understand the complexity of the problem, there are several terms related to opioid use that need to be defined: opioid addiction, opioid abuse, and aberrant drug taking behavior (ADTB). According to West and Brown in their book Theory of Addiction (2012), addiction is defined as a "chronic condition in which there is a repeated powerful motivation to engage in a rewarding behavior, acquired as a result of engaging in that behavior, that has significant potential for unintended harm. It is not all-or-none, but a matter of degree" [14] .
The second term is opioid abuse. In general, substance abuse is an initial step toward addiction and dependence. The World Health Organization (WHO) defines substance abuse as "the harmful or hazardous use of psychoactive substances, including alcohol and illicit drugs" [15] . Some attributes that characterize substance abuse are failure to fulfill social or work obligations, continued use of a substance in hazardous situations, legal problems related to substance abuse, and persistent use despite continued and recurrent problems [16] .
Substance abuse and dependence are now combined into "substance use disorder" (SUD), which is measured on a continuum from mild to severe according to Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM 5). As this area of study has developed, so have the defining criteria related to substance use disorders. Categorization within the spectrum of SUD requires at least two to three symptoms-instead of one-from a list of 11 criteria for mild stage [17] . While these criteria are available in detail at www.DSM5. org [17] , it is important to note that the tolerance criterion, including withdrawal symptoms, for opioid use disorder "does not apply for diminished effect when used appropriately under medical supervision" [18] .
The last term is aberrant drug taking behaviors (ADTB), which are defined as "behaviors that are more likely to be associated with medication abuse and/or addiction" [19] . Examples of these behaviors are 1) selling prescription drugs; 2) concurrently abusing alcohol or other illicit drugs; and 3) "losing" prescribed medication on multiple occasions [20] [21] [22] . It is worth mentioning that some behaviors could look like ADBT but in fact they might indicate undertreatment or maybe are more a part of stabilizing the pain condition [23] . Examples of these behaviors are 1) asking for, or even demanding, more medication; 2) asking for specific medications; and 3) use of the pain medication to treat other symptoms [23] . Despite the evolving nature of these terminologies, it is important for researchers and treating prescribers to understand that there is a spectrum of addiction.
Due to the shortage of pain specialists, primary care providers (PCPs) provide the majority of pain care [24] . However, due to limited education and training in pain management, among other factors, PCPs have characterized providing chronic pain care as frustrating [25] [26] [27] [28] [29] [30] . Thus, relying on clinical judgment alone may misguide clinicians in choosing the proper course of action for patients with chronic pain.
To account for the prescribers' need to improve opioid therapy outcomes, multiple previous studies were conducted to develop, evaluate, and compare tools for predicting risk of developing aberrant drug-related behaviors [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] . The majority of these studies examined selfreport tools such as the Screener and Opioid Assessment for Patients in Pain (SOAPP), Opioid Risk Tool (ORT), and Current Opioid Misuse Measure (COMM). This study found only one systematic review that discussed opioid risk assessment tools extensively [46] , and most of the examined articles only review selfreport tools. There have been fewer studies dedicated to the evaluation of predictive statistical models derived from databases. To explain the difference, we defined a self-report risk assessment tool as a tool designed to predict the risk of current or future opioid aberrant behavior based on predictive variables reported by the patient or the physician. Additionally, we defined a database risk assessment tool as a tool designed to predict the risk of current or future opioid aberrant behavior based on predictive variables extracted from electronic health record or administrative claims data. Figure 1 provides a schematic of how opioid risk assessment tools were categorized. Thus, the aim of this systematic review was to answer the following questions: 1) What variables have been examined in the literature to predict opioid abuse? 2) What are the methods (population, database, and analysis) used to develop the statistical models to create the tool? 3) How were the outcomes defined in each statistical model?
Method
A pharmacist with research experience used EBSCO and PubMed to conduct a two-stage systematic search to identify several articles directly related to the topicopioid risk assessment. First, the pharmacist identified eight articles deemed to be directly related to the topic. The second step was to conduct a systematic search using OVID to generate a list of articles that should have all eight articles of relevance. The idea behind choosing this method was ensuring that all common articles of relevance were included in one combined search, which perhaps would yield more new articles related to the topic as well. Finally, authors of some of the articles found were contacted, mainly through e-mail or over the phone to request further data about their work or to identify other related work.
Thus, the primary database searched for this study was OVID. The search was conducted using a combination of three search terms, including "opioids," "risk assessment," and "decision support" (Figure 2 ). The search was limited to articles written in English featuring human adult subjects that were published between January 1990 and April 2016. This search generated 1,409 articles. Duplicate articles were automatically checked using Endnote X7 and then manually reviewed. Out of 1,409 articles, 43 articles were duplicates and were excluded. The pharmacist reviewed the titles and abstracts of the remaining 1,366 articles. The inclusion/exclusion criteria were the following (the included articles were original studies, not narrative reviews):
1. The included studies focused on the risk for aberrant drug-related behaviors.
2. Studies included quantitative data specific to prediction capability (odds ratio, P value, or confidence interval).
3. Studies that focused on self-administered tools were excluded.
4. Only studies that used algorithms to predict opioid abuse from data extracted from electronic health records or administrative claims were included.
After applying the inclusion/exclusion criteria, 27 full text articles were downloaded. Of these articles, 20 articles were excluded because of their focus on self-report tools ( Figure 2 ). Variables of interest were extracted and listed on an Excel sheet for all seven articles included.
To check face validity and data consistency, a primary care physician reviewed extracted data, including variables from articles, categorization of variables from articles, method (population, database, analysis) used, and outcome definition (opioid abuse).
Results
During our systematic review, we identified seven articles (nine models) to assess opioid risk from databases (claims data or EHR), which will be the subject of this review. All nine models provided definitions of the outcome of opioid abuse as well as variables used to predict the outcome. The following sections will discuss important findings with regards to variables, methods, and outcome definitions for the coinciding models.
Variables
Among retrieved studies, nine models and 75 distinct variables were identified. The variables were grouped into seven main categories; demographics (six variables), medications (33 variables), care utilization visits (three variables), behavior (seven variables), mental status (one variable), pain and medical comorbidities (15 variables), pain (four variables), and family history of substance abuse and comorbidities (six variables). The identified models most commonly included demographic variables; age and gender were mentioned in all nine models. History of alcohol abuse, smoking status, and mental diagnosis were mentioned in five models. Table 1 lists all variables mentioned in three models or more out of nine models.
Source of data

Figure 1
Overview of sources and purpose of opioid risk assessment tools.
Review: Opioid Abuse Predictive Model
Method: Studied Population, Database Used, Analysis
As mentioned previously, this review found three studies that used administrative claims data and four studies that used electronic health record data. In one of the four articles, a disease management program database was used in addition to health record data. The number of patients included in the studies varied greatly from 196 to 1,552,489. Studies that used ICD-9 codes as a primary source of defining their cohort included larger sample sizes compared with studies that did not use ICD codes. This sample size variation is related to study design and coincides with the nature of data used. Administrative claims data is likely national data, while EMR data is representative of a single site or single health care system. The inclusion criteria for a study's population were similar; age from 12 (or 18) to 64 years, at least one claim for a prescription opioid in the past 12 months, or a history of receiving opioids for 30 to 90 consecutive days. Exclusion criteria were cancer pain and heroin poisoning. Table 2 details the methods for each article. Finally, in terms of analysis used, all studies used logistic regression as their primary multivariate analysis method. Using logistic regression for this purpose is consistent with the common practice in the field, which recommends using logistic regression to analyze a dichotomous independent variable (e.g., opioid abusers vs nonabusers) [47] . Some of the studies preliminarily analyzed variables in bivariate analysis, with the significant variables ultimately entered into the multivariate model.
Outcome Definition
The examined articles defined the outcome of opioid abuse differently. Specifically, four out of seven articles (six out of nine models) depended primarily on presence Figure 2 Article extraction process (PRISMA).
Alzeer et al. or absence of an opioid abuse or dependence diagnosis according to ICD-9 codes, while the other two studies used a predefined list of opioid-related aberrant behaviors. Additionally, they also reviewed a patient's profile for any release from the pain management program due to aberrant behaviors. The last article and respective model used a hybrid technique that included natural language processing methods along with ICD-9 codes to define opioid problems [48] .
Discussion
Inconsistency of Prediction Direction of Variables
Of note, we found inconsistency in the ability of individual variables to predict the outcome (aberrant drugrelated behavior Zale et al. (2014) conducted the first study of its kind to test "whether varying levels of current/historical smoking and indices of smoking heaviness/nicotine dependence may be associated with greater likelihood of past-year prescription opioid misuse in the general population" [49] . The study found a positive association between level of smoking heaviness/nicotine dependence and opioid misuse [49] . Other variables, such as gender, number of opioid prescriptions, early refills, inpatient hospitalization days, days with physical care visits, nonopioid substance abuse/dependence, number of morphine prescriptions, and number of opioid prescribers, were all consistent risk factors across the models. Other variables such as age (older groups) and tramadol use were consistently reported as protective variables (Table 2) .
Claims Data vs Electronic Health Record Data
Using a specific type of database (administrative claims data vs electronic health record data) could potentially alter development of the model design. For example, administrative claim databases generally provide a consistent data format because they use a predefined set of codes [50] . As a result, it is relatively easier to create a study cohort using claims data compared with most electronic health records databases. However, one potential disadvantage of using claims data is that the care providers do not always document these relevant codes. This incomplete documentation leads to missing outcomes of interest for some patients [51, 52] . On the other hand, using electronic health record databases, which have much richer clinical data (for each patient) [50] , can facilitate improved cohort/outcome definitions. Specificity within the cohort can be achieved by reviewing some aspects of the patient's file manually or using some advanced tools to define the study cohort based on certain metrics (e.g., estimated glomerular filtration rate to define chronic kidney failure patients) [50] .
Variation in Outcome Definition
The International Classification of Diseases (ICD) is a diagnostic coding system that can be used to categorize patients. However, the issue with creating a model based on an outcome structured by ICD codes is the fact that these codes often understate the actual number of patients exhibiting the target categorization [53, 54] . This means those patients who are labeled with opioid problems according to ICD codes are likely to have an opioid problem; however, ICD codes may overlook other patients who have opioid problems that were not documented [53] . This could be due to an intentional lack of documentation or, in other cases, prescribers trying to avoid stigmatizing patients with opioid problems by not using these codes [53] . The issue of underdocumentation in particular can create less representative models. Another limitation to the models found is the fact that most of these models were based on claims data, which are less likely to provide the in-depth and detailed clinical data available in an electronic health record database.
The variation in the outcome definition across studies and its potential effect can be noticed in the self-report opioid risk assessment tools as well. When tools such as SOAPP-R (SOAPP revised) or ORT are validated across different populations or when different definitions of the outcome are used, the prediction sensitivity and specificity change greatly.
SOAPP-R is a self-report questionnaire designed to predict aberrant medication-related behaviors among persons with chronic pain [55] . SOAPP-R came as a revised version for the original SOAPP, an instrument developed by Inflexxion (Newton, MA, USA) with support from Endo Pharmaceuticals and the National Institute on Drug Abuse [56] . Version 1 is considered an "initial step toward development of a screener for aberrant medication-related behaviors in chronic pain patients" [57] . SOAPP-R is one of the most validated tools; based on the literature, there is large variation in its sensitivity. The sensitivity and specificity of SOAPP were 91% and 69% in one study [58] and 39.2% and 69.3% in another [45] . The same statement can be applied to ORT as well. One study reported a sensitivity of 45% [59] , and the other study reported sensitivity as low as 19.5% [45] .
One way to explain the variation in opioid risk assessment tools' performance could be due to differences in outcome definitions in the reviewed validation studies. For example, SOAPP performance was measured in some studies based on a positive result on the Aberrant Drug Behavior Index (ADBI) [35, 60] , while in other studies it was measured based on the presence of a discharge review form [43] . At present, such crosscomparisons for opioid risk assessment models, which are based on databases, are not yet possible due to a lack of further validation from multiple studies for any of the models found. However, this review indicates that more effort in the future to utilize secondary data analysis is likely. This is due to the necessity of developing more accurate and comprehensive models from current and future health system electronic records.
However, these future efforts will surely face an interesting challenge considering that, as of 2016, most of organizational data are unstructured, and health care data are no exception. According to IBM, in 2015 unstructured data represented 80% of the total health data [61] . Thus, it is important for future efforts to utilize the untapped potential of unstructured data to develop an opioid addiction model that uses data mining techniques.
Another aspect of defining outcomes is the cohort follow-up period. Whether the studies retrieved were retrospective or prospective, the covered period to measure the outcome ranged from three months in one model, including 12 months in six models, to 24 months in one model, and finally 24 to 60 months (a combination of pre-indexing period and postindexing period). This variation in period of follow-up might have an unforeseeable impact on the prediction accuracy of the models. For example, a period of three months of follow-up may not be sufficient to detect opioid-related aberrant behaviors. Thus, patients might be categorized as "false negative" as a result.
Limitations
There are only seven studies, including nine models, that met our inclusion criteria. This could be due to using only one search engine, OVID Medline. However, the study's search terms were exhaustive and used results from a combined three-search session to mitigate this shortcoming (Figure 2 ). Another reason for the relatively small number of articles is the exclusion of self-report opioid risk assessment methods (21 articles). The justification for omitting these articles is specific to the study questions. The study attempts to identify variables and resources used for the design of models based on databases, electronic health records, and administrative claim data. Another limitation related to data collection is having only one primary care physician to check for face validity and data consistency. Having another reviewer and reporting inter-rater reliability could add value to the study. In our case, this was not feasible due to limited funds and resources available for the study.
A second limitation pertains to the quantitative analysis of the variables found, which did not include the magnitude of the odds ratio or significance of the P values for each variable. Rather, the analysis only describes a variable's rule in terms of being a risk factor or protective measure (Table 1 ). This was due to a lack of reporting odds ratios in two articles and P values in a third article. These two articles did not report the odds data for the insignificant variables while the third article did not report any P values for the model (but reported adjusted ORs and CIs instead). Finally, the way the articles categorized the variable subset varied across the model. For example, the variable age was subcategorized into six age groups while it was treated as a continuous variable in the other. Moreover, the reference group varied among models as well. In the same example of the variable "age," one model identified the older age subgroup as a reference group while five models identified the younger age subgroup as a reference and one article identified middle age [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] as a reference group.
A third limitation of this review is the inconsistency in the definition of the outcome, opioid abuse, across the articles. Despite a description and analysis of the same issues, the particular definitions employed varied across articles. Smith et al. [62] examined the issue of definition inconsistency in 2013. The study summarized differences between multiple opioid use disorder terminologies based on experts' opinions. The study found that the term "misuse" "emphasize[d that] the use of the substance does not follow medical indications or prescribed dosing" [62] . However, the term "abuse" is commonly applied to substance use for nontherapeutic purposes. Substance "addiction," on other hand, was defined as "compulsive substance use that occurs despite personal harm or negative consequences" [62] . To address this variation of the definition in the examined articles, we summarized the outcome definitions of each article in Table 2 .
Our analysis was limited to the data provided in the articles. Thus, access to certain data that measured models' performance, such as c-statistics, sensitivity, and specificity for analyzed models, was not available.
Opioid risk assessment tools are becoming standard practice in pain and primary clinics prior to and during prescribing opioid therapy for chronic pain. However, this review indicates that there is inter-/intravariation in these tools' performance for assessing opioid abuse. This review concludes that this variation can be explained by the variation in study period, sample size, opioid abuse definition, type of database, and structured documentation to ICD codes.
Summary/Conclusion
Opioid risk assessment tools are becoming standard practice in pain and primary clinics prior to and during prescribing opioid therapy for chronic pain. However, this review indicates that there is inter-/intravariation in these tools' performance for assessing opioid abuse.
Review: Opioid Abuse Predictive Model
This review concludes that this variation can be explained by the variation in study period, sample size, opioid abuse definition, type of database, and structured documentation to ICD codes.
In addition, this review illustrates an overview of common methods of opioid risk assessment tools and categorizes them based on the method of reporting into self-report and database-related models. Moreover, the study provides a comparison between the two categories whenever possible.
This systematic review presents a list of variables that were used to predict opioid abuse from electronic health record and administrative data. Furthermore, the review provides a count of how many times each variable was mentioned and how often it was counted as a risk factor or protective measure in the literature. To our knowledge, this is the only systematic review that has done so. Providing such data to researchers could lead to developing a tool that is more accurate in predicting the risk of developing aberrant drug-related behaviors.
The review also identifies and compares other aspects related to opioid risk assessment model design such as period of the study, number of patients, subject inclusion criteria, and ICD-9 code used to identify patients from the database.
The study highlights the major differences between articles in defining opioid abuse derived from databases for the purpose of developing opioid use risk assessment tools. This could help future researchers build on previous work to create advanced models for improved predictability of opioid abuse.
Despite the availability and presence of many self-report and database-oriented risk assessment tools, prescribers might not yet rely solely on these tools due to their lack of validation and consistency in their results. However, opioid risk assessment procedures can be improved by enhancing structured data capturing by the electronic health record system. Physicians and nurses can play a major role in this step by documenting the proper ICD code that identifies specifically the category of opioid abuse for patients. Clinical practices and hospitals should pay attention to the viability of adopting these tools into their practice. Some expected barriers to adoption of these tools are the population variation from within the clinic where the tool was validated, procedural differences, including differences in outcome definitions between clinics, and lack of proper technical experience to implement these tools. 
